Macquarie Group LTD Bausch Health Companies Inc. Transaction History
Macquarie Group LTD
- $86.4 Billion
- Q4 2024
A detailed history of Macquarie Group LTD transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 6,600,000 shares of BHC stock, worth $47.4 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
6,600,000
Previous 6,600,000
-0.0%
Holding current value
$47.4 Million
Previous $53.8 Million
1.1%
% of portfolio
0.06%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding BHC
# of Institutions
270Shares Held
252MCall Options Held
5.12MPut Options Held
9.43M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$249 Million3.8% of portfolio
-
Goldentree Asset Management LP New York, NY27.5MShares$198 Million16.77% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$190 Million12.9% of portfolio
-
National Bank Of Canada15.4MShares$111 Million0.17% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$93.3 Million0.23% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.6B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...